|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 701 Pennsylvania Ave., NW Suite 720 |
Address2 | |
| City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 5632-12
|
||||||||
|
6. House ID# 312570000
|
||||||||
| TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Ronald F. Docksai, Ph.D. Vice President Federal Government Relations |
Date | 10/20/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
HR 1549/S 619 The Federal Food Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provisions in the bill.)
HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 Food Safety. Monitoring food safety provisions.)
H. Res 317/S. Res 174 Recognizing Kansas and Missouri as the animal health corridor in the US; (Support for the bill.)
HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
HR 21 To establish a national policy for our oceans, to strengthen the National Oceanic and Atmospheric Administration to establish a national and regional ocean governance structure, and for other purposes; (Provisions related to regulations/changes to upstream activities that could affect agriculture.)
S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the
United States; (Provisions related to agriculture activites and the section changing the definition of U.S. waters.)
HR 2454 To create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions related to agriculture activities, allowances/offsets and credits building efficiencies and the "cap and trade" system for agriculture.)
Regulatory Biotech Issues; (Provisions in proposed regulations regarding the approval of biotech traits and all other issues related to biotech regulations, in particular APHIS Part 340.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
ESA Issues; (NMFS Biological opinions -- Discussions on a National Marine Fisheries Biological Opinions that were recently released and their potential affects on agriculture.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
H Res 317/S Res 174 Recognizing Kansas and Missouri as the animal health corridor in the US; (Support for resolution.)
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)
HR 3519/S 1709 Veterinary Services Investment Act; (Support for legislation.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HR 2997/S 1406 Making appropriations for Agriculture, Rural Development, Food and Drug Administration and Related Agencies programs for the fiscal year ending September 30, 2010, and for other purposes; (All provisions related to agriculture research funding, funding of conservation programs and funding of USDA agencies including APHIS and FAS.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Spurgat |
Ms. |
|
|
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdicition of the United States over waters of the United States; (Provisions related to agriculture activities and the section changing the definition of U.S. Waters.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
HR 2868 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism against chemical facilities, and for other purposes; (Provisions relating to sensitive security information and citizen action suits.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
HR 2892 A bill making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2010 and for other purposes; (Provisions relating to chemical plant security.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
The Executive Budget for Fiscal Year 2010; (Provisions related to preserving ERISA protection.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HR 1105 Making omnibus appropriations for the fiscal year ending September 30, 2009, and for other purposes; (Provisions relating to cell therapy delivery for NASA and provisions relating to contract efficiency with the University of Mississippi.)
HR 1 American Recovery and Reinvestment Act of 2009; (Provisions related to stimulus funding in Western Pennsylvania for regional medical device sterilization facility.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S 515 The Patent Reform Act of 2009; (Provisions relating to IPP corporate protection.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S 515 A bill to amend title 35, United States Code, to provide for patent reform; (Provisions relating to apportionment of damages.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S 515 A bill to amend title 35, US Code to provide for patent reform; (Sec 4: Provisions related to the right of the inventor to obtain damages, Sect. 5: Provisions related to Post Grant Procedures.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
HR 2454 To create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (Provisions relating to agriculture.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions relating to the definition of navigable waters.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
HR 2454 The American Clean Energy and Security Act of 2009, a bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions pertaining to the advancement of a Cap and Trade greenhouse gas reduction and energy efficiency measures.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIN
16. Specific lobbying issues
HR 679 The American Recovery and Reinvestment Act of 2009; (Provisions maintaining tax payer protections.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
S 593 The Ban Poisonous Act of 2009, A bill to ban the use of bisphenol A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions
and amendments pertaining to the ban and the testing are relevant.)
HR 6228 The Ban Poisonous Substance Act of 2009, a ban in all food and other containers; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A products.)
HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S 593 The Ban Poisonous Act of 2009, A bill to ban the use of bisphenol A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions
and amendments pertaining to the ban and the testing are relevant.)
HR 6228 The Ban Poisonous Substance Act of 2009, a ban in all food and other containers; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A products.)
HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1549/S 619 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II, General provisions in the bill.)
HR 2749 Food Safety Enhancement Act of 2009, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title I Food Safety, Monitoring food safety provisions.)
HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.)
HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
HR 2749 food Safety Enhancement Act of 2009, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title I Food Safety. Monitoring food safety provisions.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1346/S 540 Medical Device Safety Act; (Provisions relating to preserving patient access.)
HR 1085 Health Insurance Coverage Protection Act; (Provisions relating to preserving medical products availability.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1085 Health Insurance Coverage Protection Act; (Sections relating to insurance caps.)
HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All relating to follow on biologics.)
HR 1548 Pathway for biosimilars Act; (All relating to follow on biologics.)
HR 1321 Healthy Americans Act; (Relating to Medicare.)
Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.)
S 1142 The "Informed Health Care Decision Making Act of 2009; (Sections pertaining to comparative effectiveness.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 3200 America's Affordable Health choices Act of 2009; (all provisions dealing with prescription medicines and medical devices.)
Senate Finance Committee Health Care Reform Proposal; (All provisions dealing with prescription medicines and medical devices.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Corcoran |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1105 Making omnibus appropriations for the fiscal year ending September 30, 2009 and for other purposes; (Provisions relating to cell therapy delivery for NASA and provisions relating to contract efficiency with the University of Mississsippi.)
HR 1 American Recovery and Reinvestment Act of 2009; (Provisions related to stimulus funding in Western Pennsylvania for regional medical device sterilization facility.)
Americas Health Future Act; (Provisions related to utilization rate and medical device industry fee)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
HR 2868 Chemical Facility Anti-terrorism Act of 2009, a bill to amend the Homeland Security Act of 2009; (All provisions related to the enhancement and protection of chemical facilities against acts of terrorism.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
HR 2892/S 1298 Fiscal 2010 Homeland Security Appropriations, Making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2010, and for other purposes; (General provisions of the bill.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 1085 Health Insurance Coverage Protection Act; (sections relating to insurance caps.)
Senate Finance Committee Chairman's Mark, America's Health Future Act of 2009; (All provisions.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
HR 1409/S 560 the Employees Free Choice Act; (all provisions related to preserving employees rights.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
HR 1409/S 560 Employee Free Choice Act; (Provisions related to card check.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MAN
16. Specific lobbying issues
S 515 A bill to amend title 35, United States Code, to provide for patent reform; (Provisions relating to apportionment of damages.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 1085 Health Insurance Coverage Protection Act; (Sections relating to insurance caps.)
HR 1321 Healthy Americans Act; (Relating to Medicare.)
Senate Finance Committee Chairmans's Mark, America's Healthy Future Act of 2009; (All provisions)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 1105 Making omnibus appropriations for the fiscal year ending September 30, 2009, and for other purposes; (Provisions relating to cell therapy delivery for NASA and provisions relating to contract efficiency with the University of Mississippi.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert D. |
Thomas |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All relating to follow on biologics.)
HR 1548 Pathway for Biosimilars Act; (All relating to follow on biologics.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RRR
16. Specific lobbying issues
HR 233/S 146 Railroad Antitrust Enforcement Act of 2009, a bill to amend federal anti-trust laws to provide expanded coverage and to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads; (all provisions pertaining to the "common carrier" provisions of the Staggers Act and injunctive relief for exemptions contrary to the public interest.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Miscellaneous Tariff Bill: To seek introduction of bills (no numbers yet); (To provide duty suspension or duty redution on chemicals as listed below:
A bill to suspend temporarily the duty on Olympus WG70
A bill to reduce temporarily the duty on Spirotetramat
A bill to suspend temporarily the duty on Flubendiamide
A bill to reduce temporarily the duty on AE 0172747 Ether
A bill to suspend temporarily the duty on 1,3-Cyclohexanedione.
A bill to extend the temporary suspension of duty on Trichloroacetaldehyde (Chloral)
A bill to extend the temporary suspension of duty on p-chlorobenzaldehyde
A bill to suspend temporarily the duty on mixtures containing 5-Cyclospropyl-4-2(2-Methylsulfonyl-4-Trifluoromethylbenoxyl)Isoxazole
(BALANCE PRO)
A bill to suspend temporarily the duty on Isoxaflutole
A bill to extend the reduction of duty on product mixtures containing Iprodione: 3-(3-5,dicholorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide and application adjuvants
(ROVRAL)
A bill to extend the temporary suspension of duty on 2-Acetylbutyrolactone
A bill to extend the temporary reduction in duty on Beta-cyfluthrin
A bill to extend the temporary suspension of duty on Cyfluthrin
A bill to temporary suspend the general rate of duty on Clothianidin
A bill to extend the temporary suspension of duty on Ethoprop
A bill to extend the temporary suspension of duty on product mixtures containing Foramsulfuron and Iodosulfuronmethyl-sodium (Equip)
A bill to extend the temporary suspension of duty on Isoxadifen-Ethyl
A bill to extend the temporary reduction of duty on Trifloxystrobin
A bill to extend the temporary suspension of duty on Spiromesifen
A bill to suspend temporarily the duty on Thiencarbazone-methyl
A bill to extend the temporary suspension of duty on FOE Hydroxy
A bill to reduce temporarily the duty on product mixtures containing Tembotrione and application adjuvants
( LAUDIS)
A bill to suspend temporarily the duty on products containing (E)-N-[(2-Chloro-1,3-thiazol-5-yl) methyl]-N-methyl[oxido(oxo)hydrazono] methanediamine or N-[(2-Chloro-1,3-thiazol-5-yl)methyl]-N-{(E)-(methylamino) [oxido(oxo)hydrazono] methyl}amine and application adjucants
(PONCHO)
A bill to suspend temporarily the duty on 2(Methylthio)-4-(trifluoromethyl) benzoic acid CAS [142994-05-6]
A bill to suspend temporarily the duty on 2-Chloro-6-(methylthio)toluene (CAS [82961-52-2])
A bill to suspend temporarily the duty on products containing 3-Mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-yl 3,3-dimethylbutyrate and application adjuvants
(OBERON & FORBID)
A bill to suspend temporarily the duty on mixtures containing Pyrasulfotole: 5-Hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone; and Bromoxynil Octanoate: 2,4-Dibromo-6-cyanophenyl octanoate; and Bromoxynil Heptanoate: 2,4-Dibromo-6-cyanophenyl heptanoate
(HUSKIE)
A bill to suspend temporarily the duty on 1,3-Dimethyl-1H-pyrazol-5-ol and 1,3-Dimethylpyrazol-5-one (CAS [5203-77-0], [2749-59-9])
A bill to reduce temporarily the duty on product mixtures containing Thiencarbazone-methyl: Methyl 4-({[(3-methoxy-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)carbonyl]amino}sulfonyl)-5-methylthiophene-3-carboxylate and Isoxadifen-ethyl: ethyl 4,5-dihydro-5,5-diphenyl-1,2-oxazole-3-carboxylate and Tembotrione: 2-{2-Chloro-4-mesyl-3-[(trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione and application adjuvants (HTSUS 3808.93.15; CAS: 317815-83-1, 163520-33-0, 335104-84-2)
(CAPRENO)
A bill to suspend temporarily the duty on Cyprosulfamide: N-({4-[(Cyclopropylamino) carbonyl]phenyl}sulfonyl)-2-methoxybenzamide (CAS No. Cyprosulfamide: 221667-31-8)
A bill to extend the temporary reduction of duty on ACM
A bill to reduce temporarily the duty on Oxadiazon
A bill to extend the temporary suspension of duty on mixtures of methyl 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] benzoate, sodium salt (Iodosulfuron methyl, sodium salt) and application adjuvants
(AUTUMN)
A bill to extend the temporary suspension of duty on Mesosulfuronmethyl
(OSPREY & SILVERADO)
A bill to suspend temporarily the duty on mixtures containing Ethyl(R)-2-[4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy]propionate (Fenoxaprop Ethyl), (CAS No. 71283-80-2), 5-hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone (Pyrafulfotole) (CAS No. 365400-11-9), 2,6-dibromo-4-cyanophenyl octanoate (Bromoxynil octanoate) (CAS No. 1689-99-2), and 2,6-dibromo-4-cyanophenyl heptanoate (Bromoxynil heptanoate) (CAS No. 56634-95-8)
(WOLVERINE)
A bill to suspend temporarily the duty on 1,2,4 Triazole
A bill to suspend temporarily the duty on Fluopicolide
A bill to suspend temporarily the duty on Fenhexamid
A bill to suspend temporarily the duty on BELT & SYNAPSE
A bill to extend the temporary suspension of duty on Phenmedipham
A bill to extend the temporary suspension of duty on Propiconazole
A bill to extend the temporary suspension of duty on PREVICUR
A bill to extend the temporary suspension of duty on 2,4-dichloroaniline
A bill to extend the temporary reduction in duty of Aluminum tris (O-ethylphosphonate) whether or not mixed with application adjuvants
(FOSETYL-AL)
A bill to suspend temporarily the duty on 2,2-Dimethylbutanoic acid 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro(4.5)dec-3-en-4-yl ester (Spirodiclofen)
A bill to extend the temporary suspension of duty on Fenamidone
A bill to temporarily suspend the duty on cyclopropane-1,1-dicarboxylic acid, dimethyl ester
A bill to suspend temporarily the duty on Pyrasulfotole
A bill to extend the temporary suspension of duty on Pyrimethanil
A bill to reduce temporarily the duty on CORVUS herbicide
A bill to reduce temporarily the duty on EVERGOL
A bill to reduce temporarily the duty on Imidacloprid Pesticides
A bill to suspend temporarily the duty on LIBERTY, RELY and IGNITE herbicides
A bill to reduce the temporarily the duty on Imidacloprid Technical
A bill to extend the temporary suspension of duty on OPTION & REVOLVER
Herbicides
A bill to extend the temporary suspension of duty on 2,6-dibromo-4-cyanophenyl octanoate/heptanoate (Bromoxynil Octanoate / Heptanoate)
A bill to suspend temporarily the product mixtures containing Methyl 2-[({[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl}amino)sulfonyl]-4- [(mesylamino)methyl]benzoate (Mesosulfuron-methyl) and Methyl 4-iodo-2-[3-(4-methoxy -6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl]benzoate, sodium salt (Iodosulfuron-methyl-sodium), whether or not mixed with application adjuvants (HTSUS 3808.93.15; CAS 208465-21-8 144550-36-7)
(ATLANTIS)
A bill to suspend temporarily the duty on certain mixtures containing [3-[(6-chloro-3-pridinyl)methyl]-2-thiazolidinylidene]cyanamide
(CALYPSO)
A bill to extend the temporary suspension of duty on Permethrin
A bill to extend the temporary suspension of duty on 2-Chlorobenzyl chloride (O-Chlorobenzylchloride)
A bill to suspend temporarily the duty on product mixtures containing Imidacloprid: 1-(6-Chloro-3-pyridinyl)methyl-N-nitroimidazolidin-2-ylidene amine Z9: (9Z)-9-Tricosene
(MAXFORCE WG10 & GR0.5)
A bill to extend the temporary suspension of duty on Resmethrin
A bill to extend the temporary suspension of duty on N-3[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)benzamide
(Flutolanil)
A bill to extend the temporary suspension of duty on product mixtures containing 2-(4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-yl)carboxamidosulfonylbenzoate; sodium (4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-ylcarbonyl)(2-methoxycarbonylphenylsulfonyl)azanide & methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-a-(methanesulfonamido)-p-toluate (HTSUS 3808.93.15 AND 9902.24.42; CAS 181274-15-7, 208465-21-8)
(RIMFIRE & OLYMPUS FLEX)
To suspend temporarily the duty on Tembotrione
A bill to extend the temporary suspension of duty on Deltamethrin
A bill to suspend temporarily the duty on Hydrazine Hydrate Solution
A bill to extend the temporary reduction of duty on Triadimefon (Bayleton
Technical)
A bill to extend the temporary reduction of duty on Ethofumesate in bulk or mixtures.
A bill to reduce temporarily the duty on product mixtures containing Imidacloprid: 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine and Cyfluthrin:
Cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclo-propanecarboxylate and application adjuvants (HTSUS 3808.91.25; CAS 138261-41-3, 68359-37-5)
(LEVERAGE )
A bill to reduce temporarily the duty on product mixtures containing Imidacloprid: 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine and Beta-Cyfluthrin:
(RS)-a-cyano-4-fluro-3-phenoxybenzyl(1RS,3RS;1RS,3SR)-2-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate and application adjuvants (HTSUS 3808.91.25; CAS 138261-41-3, 68359-37-5)
(LEVERAGE 360)
A bill to reduce temporarily the duty on Benzamide, N-[2-[3-chloro-5 (trifluoromethyl) 2-pyridinyl]ethyl]-2-(trifluoromethyl) (FLUOPYRAM) whether or not mixed with application adjuvants
(FLUOPYRAM)
A bill to suspend temporarily the duty on 1,3,5-Triazine-2,4-diamine, N-[(1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1-yl]-6-(1-fluoroethyl) (INDAZIFLAM) whether or not mixed with application adjuvants
(HTSUS 2933.69.60; CAS 950782-86-2) )
(INDAZIFLAM)
Miscellaneous Tariff Bill; Bayer CropScience had previously requested several chemicals to be included in the Miscellaneous Tariff Bill that are no longer part of the companys request. Bayer CropScience has asked that the following bills or chemicals not be included in the Miscellaneous Tariff Bill on the companys behalf.
A bill to suspend temporarily the duty on Thionyl chloride
A bill to extend the temporary suspension of duty on Phosphorus Thiochloride (PSCL3)
A bill to suspend the temporary duty suspension on Sodium Methylate Solution
A bill to suspend temporarily the duty on Spiroxamine
A bill to extend the temporary suspension of duty on Desmedipham in bulk or mixtures
A bill to extend the temporary suspension of duty on Phenmedipham
A bill to extend the temporary duty suspension on NORTRON SC to be replaced with a bill to extend the temporary reduction of duty on Ethofumesate in bulk or mixtures
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
|
Jennifer |
Spurgat |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Miscellaneous Tariff Bill (no number yet): To seek introduction of bills (no numbers yet); (To provide duty suspension or duty reduction on chemicals as listed below:
A bill to extend the temporary suspension of duty on o-Acetylsalicylic acid (Asprin).
A bill to suspend temporarily the duty on Propoxur (Sedran Technical).
A bill to extend the suspension of duty on 2-Oxepanone polymer with 1,4-butanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-ethyl-1-hexanol-blocked (Crelan).
A bill to extend suspension of duty on Mixtures of tris(4-isocyanatophenyl)thiophosphate) in solvents (Desmondur RF-E).
A bill to extend the suspension of duty on Copolymer of methyl ethyl ketoximine and toluene diisocyanate (Desmondur BL XP).
A bill to extend the suspension of duty on 1,3-Diisocyanatomethylbenzene, polymer with 1,6-diisocyanatohexane (Desmondur VP HL).
A bill to extend the suspension of duty on Poly(toluene diisocyanate) (Desmondur IL BA).
A bill to extend the suspension of duty on A linear aromatic polyurethane prepolymer based on toluene diisocyanate. (Desmondur E 14).
A bill to extend the suspension of duty on Polyisocyanate cross linking agent products containing triphenylmethane triisocyanate in solvents (Desmondur R-E).
A bill to extend extend the suspension of duty on Hexane, 1-6-diisocyanato-,homopolymer, 3,5-dimethyl-1H-pyrazole-blocked in solvents (Desmondur VP LS 2253).
A bill to extend the suspension of duty on Mixtures of Methyl o-toluenesulonate and methyl p-toluenesulfonate (TSME).
A bill to extend the suspension of duty on Trimethylopropane tris(3-aziridinylpropanoate) (Xama 2).
A bill to extend the suspension of duty on Polyfunctional aziridine (Xama 7).
A bill to extend the temporary suspension of duty on D-Mannose.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Protocol Number HP-1350 US France Protocol to Income Tax Treaty; (Provisions relating to entire bill.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |